Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
2,492,253
-
Shares change
-
-263,421
-
Total reported value, excl. options
-
$8,596,457
-
Value change
-
-$920,920
-
Number of buys
-
7
-
Number of sells
-
-18
-
Price
-
$3.45
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2023
40 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2023.
XBiotech Inc. - Common Shares, no par value (XBIT) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,492,253 shares
of 33,289,095 outstanding shares and own 7.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (854,469 shares), BlackRock Inc. (262,196 shares), CREDIT SUISSE AG/ (245,270 shares), GEODE CAPITAL MANAGEMENT, LLC (155,083 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (114,340 shares), MORGAN STANLEY (87,307 shares), DIMENSIONAL FUND ADVISORS LP (75,126 shares), Connor, Clark & Lunn Investment Management Ltd. (57,916 shares), STATE STREET CORP (57,295 shares), and Bank of New York Mellon Corp (55,693 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.